Human Phenotype Project Study Protocol

Weizmann Institute of Science

Status: Enrolling

Conditions: Adult Disease

Study type: Observational

Funder types: Other

Identifiers

NCT05817734

1789-1

Details and patient eligibility

About

This is a prospective study aimed at recruiting 30,000 individuals, aged 40-70 years old, and following them longitudinally for 25 years with repeated measurements. The basic follow-up frame will include a visit to the Clinical Test Center (CTC) every two years and a phone interview every other year (on uneven years). Sample collection and biobanking will be performed every two years and online questionnaires will be filled out on an annual basis.

The primary goals are to study the variation observed across different individuals in disease susceptibility, clinical phenotypes, and therapeutic responses. The study aims at studying the complex interplay and relative contribution of different omics, physiological characteristics and lifestyle on disease pathogenesis and progression and to evaluate how these effects are mediated.

Enrollment: 30,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Ages 18+, males and females.

Exclusion criteria

• Pregnancy.
• Mentally disabled or in general legally non-competent.
• Prisoner or soldier. Soldiers: mandatory service only
• Active cancer
• Fertility Treatments (current)
• Hepatitis ( B, C), chronic or acute
• HIV
• Liver cirrhosis
• Dialysis
• Unstable medical conditions